[1]
“Comprehensive in-Silico Characterization of Deleterious IDH2 Variants and Their Structural and Functional Implications in Acute Myeloid Leukemia: In-Silico for Deleterious IDH2 Variants and Functional Implications in AML”, FBT, vol. 6, no. 2, pp. 25–32, Jun. 2026, doi: 10.54393/fbt.v6i2.238.